Complement activated C4d immunoreactive oligodendrocytes delineate small cortical plaques in multiple sclerosis

Experimental Neurology

Volumn 174, Issue 1, 2002, Pages 81-88

  Schwab, Claudia ^a   McGeer, Patrick L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Complement; Gray matter; Immunocytochemistry; Inflammation; Miniature plaques; Multiple sclerosis; Oligodendrocytes

Indexed keywords

ADULT; AGED; ARTICLE; AXONAL INJURY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; PRIORITY JOURNAL;

EID: 0036118795     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2001.7851     Document Type: Article

References (35)

1. Detection of humeral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies
2. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis
3. Cellular immune response in multiple sclerosis plaques
4. Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice
5. Immunocytochemical localization of the terminal complement complex in multiple sclerosis
6. CSF-enriched antibodies do not share specificities among MS patients
7. Macrophages in CNS remyelination: Friend or foe?
8. Intrathecal synthesis of virus-specific oligoclonal IgG, and of free kappa and free lambda oligoclonal bands in acute monosymptomatic optic neuritis. Comparison with brain MRI
9. Blood-brain barrier damage in acute multiple sclerosis plaques. An immunocytological study
10. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion
11. The pathology of multiple sclerosis: A historical perspective
12. Serum amyloid P component binds to histones and activates the classical complement pathway
13. Multiple sclerosis: A serial study using MRI in relapsing patients
14. Binding of complement component Clq to myelin oligodendrocyte glycoprotein: A novel mechanism for regulating CNS inflammation
15. Glomerular deposition of C4 cleavage fragment (C4d) and C4-binding protein in idiopathic membranous glomerulonephritis
16. Neuropathology in multiple sclerosis: New concepts
17. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
18. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide
19. Monocyte activation in multiple sclerosis
20. Aβ 42-carboxy terminal-like immunoreactivity is associated with intracellular neurofibrillary tangles and Pick bodies
21. Immune mechanisms in the pathogenesis of demyelinating diseases
22. Reversible injury of cultured rat oligodendrocytes by complement
23. Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies
24. Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement
25. MBP, anti-MBP and anti-PLP antibodies, and intrathecal complement activation in multiple sclerosis
26. Intrathecal activation of the complement system and disability in multiple sclerosis
27. Multiple sclerosis: In situ evidence for antibody- and complement-mediated demyelination
28. Axonal transection in the lesions of multiple sclerosis
29. Macrophage phagocytosis of myelin in vitro determined by flow cytometry: Phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide
30. Serial magnetic resonance scanning in multiple sclerosis: A second prospective study in relapsing patients
31. Immunofluorescence study of brain plaques from two patients with multiple sclerosis
32. Complement-activated oligodendroglia: A new pathogenic entity identified by immunostaining with antibodies to human complement proteins C3d and C4d
33. Relationship of complement-activated oligodendrocytes to reactive microglia and neuronal pathology in neurodegenerative disease
34. Interactions between oligodendrocytes and microglia. A major role for complement and tumor necrosis factor in oligodendrocyte adherence and killing
35. A cross-reactive anti-myelin basic protein idiotope in cerebrospinal fluid cells in multiple sclerosis